ENDRA Life Sciences (NDRA) Accumulated Depreciation & Amortization (2016 - 2021)
ENDRA Life Sciences (NDRA) has disclosed Accumulated Depreciation & Amortization for 6 consecutive years, with -$38057.0 as the latest value for Q3 2021.
- Quarterly Accumulated Depreciation & Amortization rose 76.92% to -$38057.0 in Q3 2021 from the year-ago period, while the trailing twelve-month figure was -$38057.0 through Sep 2021, up 76.92% year-over-year, with the annual reading at $506660.0 for FY2020, 14.39% up from the prior year.
- Accumulated Depreciation & Amortization for Q3 2021 was -$38057.0 at ENDRA Life Sciences, up from -$67880.0 in the prior quarter.
- The five-year high for Accumulated Depreciation & Amortization was $506660.0 in Q4 2020, with the low at -$164912.0 in Q3 2020.
- Average Accumulated Depreciation & Amortization over 5 years is $293353.4, with a median of $367834.0 recorded in 2018.
- The sharpest move saw Accumulated Depreciation & Amortization plummeted 135.42% in 2020, then soared 76.92% in 2021.
- Over 5 years, Accumulated Depreciation & Amortization stood at $337630.0 in 2017, then increased by 20.23% to $405946.0 in 2018, then grew by 9.11% to $442928.0 in 2019, then grew by 14.39% to $506660.0 in 2020, then crashed by 107.51% to -$38057.0 in 2021.
- According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at -$38057.0, -$67880.0, and $493085.0 for Q3 2021, Q2 2021, and Q1 2021 respectively.